McKesson Corporation $MCK Shares Sold by Scharf Investments LLC

Scharf Investments LLC lowered its stake in McKesson Corporation (NYSE:MCK) by 18.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 265,731 shares of the company’s stock after selling 59,002 shares during the period. McKesson makes up approximately 5.9% of Scharf Investments LLC’s portfolio, making the stock its 2nd biggest holding. Scharf Investments LLC owned about 0.22% of McKesson worth $217,988,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. GGM Financials LLC acquired a new position in McKesson in the 3rd quarter valued at $25,000. State of Wyoming acquired a new stake in shares of McKesson in the 2nd quarter worth $29,000. Hopwood Financial Services Inc. purchased a new stake in shares of McKesson in the third quarter valued at about $31,000. Vermillion & White Wealth Management Group LLC acquired a new position in shares of McKesson during the third quarter worth about $33,000. Finally, Board of the Pension Protection Fund acquired a new position in shares of McKesson during the fourth quarter worth about $33,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Activity at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Maria Martinez sold 349 shares of the firm’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the sale, the director directly owned 301 shares in the company, valued at $282,900.87. This represents a 53.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 3,868 shares of company stock valued at $3,743,820 in the last ninety days. 0.08% of the stock is owned by insiders.

McKesson Stock Up 0.6%

Shares of MCK stock opened at $864.99 on Wednesday. The stock has a market cap of $105.95 billion, a P/E ratio of 24.88, a P/E/G ratio of 1.38 and a beta of 0.38. McKesson Corporation has a fifty-two week low of $637.00 and a fifty-two week high of $999.00. The business has a fifty day simple moving average of $908.89 and a 200-day simple moving average of $842.77.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. During the same quarter in the previous year, the business posted $8.03 earnings per share. The firm’s quarterly revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, sell-side analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio is 9.43%.

Wall Street Analyst Weigh In

MCK has been the topic of several recent analyst reports. Barclays boosted their target price on McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 18th. Raymond James Financial set a $970.00 price target on McKesson in a research note on Thursday, March 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. Leerink Partners reissued an “outperform” rating and issued a $1,085.00 target price on shares of McKesson in a report on Thursday, March 5th. Finally, Weiss Ratings lowered shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, February 5th. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $960.93.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.